do not combine dpp-4 inhibitors with glp-1 receptor agonists recommendation GLP-1 receptor agonists GLP-1 Genetics: How Genes Affect
Description
2021 Nov 2;15:45034525
For participants who received GLP-1RAs therapy for more than six months, the intercept estimates were positive for age and gender and negative for baseline weight, indicating a potential increase in WL
safety evaluation continues in Phase 3 trials
Once-daily subcutaneous injections of liraglutide (1.8 mg starting with a 2-week dose escalation) were administered in an open-label reference arm
Rochira V, Greco C, et al
After you eat, your intestinal L-cells release GLP-1, which signals to your brain, pancreas, and digestive tract that food has arrived
